Novel Hits for N-Myristoyltransferase Inhibition Discovered by Docking-Based Screening

N-myristoyltransferase (NMT) inhibitors that were initially developed for treatment of parasitic protozoan infections, including sleeping sickness, malaria, and leismaniasis, have also shown great promise as treatment for oncological diseases. The successful transition of NMT inhibitors, which are c...

Descripción completa

Detalles Bibliográficos
Autores principales: Spassov, Danislav S., Atanasova, Mariyana, Doytchinova, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457982/
https://www.ncbi.nlm.nih.gov/pubmed/36080246
http://dx.doi.org/10.3390/molecules27175478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457982/
https://www.ncbi.nlm.nih.gov/pubmed/36080246
http://dx.doi.org/10.3390/molecules27175478

Ejemplares similares